Attività
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (77,1%), Germania (2,3%), Canada (2%), Giappone (1,9%), Cina (1,7%), Francia (1,4%), Spagna ( 0,9%), Italia (0,9%), Australia (0,9%), Brasile (0,8%), Regno Unito (0,8%) e altri (9,3%).
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Immunology
48,1
%
| 28 924 | 49,8 % | 26 136 | 48,1 % | -9,64% |
Neuroscience
14,2
%
| 6 528 | 11,2 % | 7 717 | 14,2 % | +18,21% |
Other
12,6
%
| 7 991 | 13,8 % | 6 841 | 12,6 % | -14,39% |
Oncology
10,9
%
| 6 577 | 11,3 % | 5 915 | 10,9 % | -10,07% |
Aesthetics
9,7
%
| 5 333 | 9,2 % | 5 294 | 9,7 % | -0,73% |
Eye Care
4,4
%
| 2 701 | 4,7 % | 2 415 | 4,4 % | -10,59% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
77,1
%
| 45 713 | 78,7 % | 41 883 | 77,1 % | -8,38% |
All Other Countries
9,3
%
| 4 837 | 8,3 % | 5 042 | 9,3 % | +4,24% |
Germany
2,3
%
| 1 340 | 2,3 % | 1 266 | 2,3 % | -5,52% |
Canada
2,0
%
| 1 159 | 2,0 % | 1 076 | 2,0 % | -7,16% |
Japan
1,9
%
| 956 | 1,6 % | 1 008 | 1,9 % | +5,44% |
China
1,7
%
| 912 | 1,6 % | 950 | 1,7 % | +4,17% |
France
1,4
%
| 787 | 1,4 % | 780 | 1,4 % | -0,89% |
Spain
0,9
%
| 506 | 0,9 % | 501 | 0,9 % | -0,99% |
Italy
0,9
%
| 444 | 0,8 % | 484 | 0,9 % | +9,01% |
Australia
0,9
%
| 508 | 0,9 % | 472 | 0,9 % | -7,09% |
Brazil
0,8
%
| 430 | 0,7 % | 439 | 0,8 % | +2,09% |
United Kingdom
0,8
%
| 462 | 0,8 % | 417 | 0,8 % | -9,74% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01/01/13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01/01/13 |
Robert Michael
PSD | President | 53 | 01/01/12 |
Thomas Hudson
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/01/16 |
Chief Operating Officer | 60 | 01/01/13 | |
Todd D. Bosse
IRC | Investor Relations Contact | - | 01/12/21 |
Roopal Thakkar
PRN | Corporate Officer/Principal | - | 01/01/03 |
Kevin Buckbee
AUD | Comptroller/Controller/Auditor | 58 | 01/03/23 |
Perry Siatis
LAW | General Counsel | - | 01/10/22 |
Carrie Strom
PRN | Corporate Officer/Principal | - | 08/05/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01/01/13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01/01/13 |
Director/Board Member | 70 | 01/01/13 | |
Glenn Tilton
BRD | Director/Board Member | 75 | 01/01/13 |
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01/01/13 |
Thomas Freyman
BRD | Director/Board Member | 69 | 08/05/20 |
William Burnside
BRD | Director/Board Member | 72 | 01/01/13 |
Brett Hart
BRD | Director/Board Member | 54 | 01/01/16 |
Robert Alpern
BRD | Director/Board Member | 73 | 01/01/13 |
Robert Michael
PSD | President | 53 | 01/01/12 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 830 102 293 | 1 763 861 636 ( 96,38 %) | 64 234 512 ( 3,510 %) | 96,38 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
2 749 855 | 6.62% | 3 657 307 $ | |
IM CANNABIS CORP. 5.65% | 757 172 | 5.65% | 431 588 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
AbbVie Biopharmaceuticals GmbH Taiwan Branch
| |
AbbVie AG
| |
AbbVie International SARL
| |
AbbVie Bahamas Ltd.
| |
AbbVie Pte Ltd.
AbbVie Pte Ltd. Pharmaceuticals: MajorHealth Technology AbbVie Pte Ltd. operates as a research-based pharmaceutical company. The company was founded in January 1, 2013 and is headquartered in Singapore, Singapore. |
Pharmaceuticals: Major
|
AbbVie A/S (Denmark)
AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie A/S is a Danish biopharmaceutical company that develops and manufactures medicines. The company is based in Copenhagen, Denmark. |
Pharmaceuticals: Major
|
AbbVie Biopharmaceuticals GmbH
| |
AbbVie sro
AbbVie sro Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie sro is a Czech company that develops and manufactures pharmaceutical products. The company is located in Czechia. |
Pharmaceuticals: Major
|
AbbVie Operations Singapore Pte Ltd.
AbbVie Operations Singapore Pte Ltd. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Operations Singapore Pte Ltd. is a Singaporean company that develops therapies and clinical medicines. The company is located in Singapore. |
Biotechnology
|
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+48,84% | 765 Mrd | |
-6,21% | 354 Mrd | |
+20,66% | 331 Mrd | |
+18,87% | 248 Mrd | |
-1,96% | 219 Mrd | |
+11,11% | 216 Mrd | |
+5,57% | 164 Mrd | |
-2,38% | 162 Mrd | |
+0,57% | 123 Mrd |